Leadership duties shift within CDER

01/31/2012 | Pharmalot.com

Bob Temple is giving up his post as acting director of the Office of Drug Evaluation I at the FDA's Center for Drug Evaluation and Research and will be replaced by Ellis Unger, the office's deputy director. The change will allow Temple to devote more time to his duties as deputy director for clinical science, according to CDER Director Janet Woodcock.

View Full Article in:

Pharmalot.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY